Luke O'Neill
Current position:

Luke O’Neill is Professor of Biochemistry in the School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute at Trinity College Dublin, Ireland. He is a world expert on innate immunity and inflammation. He is listed by Thompson Reuters/Clarivates in the top 1% of immunologists in the world, based on citations per paper.
Prof. O'Neill is co-founder of Sitryx, which aims to develop new medicines for inflammatory diseases. Another company he co-founded, Inflazome was recently acquired by Roche.

He has won many awards for his research including the Royal Dublin Society/Irish Times Boyle Medal for scientific excellence, the Royal Irish Academy Gold Medal for Life Sciences, the European Federation of Immunology Societies Medal, and the Landsteiner Award from the Austrian Academy of Sciences. He is a member of the Royal Irish Academy, EMBO (European Molecular Biology Organisation) and a Fellow of the Royal Society.

He also has a passion for communicating science to the public. He has a weekly radio slot on Irish radio and has published several popular science books, most recently ‘Never Mind the B#ll*cks Here’s the Science’, which won the 2020 Irish non-fiction book of the year, and ‘Keep Calm and Trust the Science – an extraordinary year in the life of an immunologist’, which was his diary during the COVID19 pandemic.

Mandate ERC Scientific Council: 01 Jan 2023 - 31 Dec 2026 (1st term)